Literature DB >> 10649292

A cell-intrinsic timer that operates during oligodendrocyte development.

B Durand1, M Raff.   

Abstract

Multicellular organisms develop on a predictable schedule that depends on both cell-intrinsic timers and sequential cell-cell interactions mediated by extracellular signals. The interplay between intracellular timers and extracellular signals is well illustrated by the development of oligodendrocytes, the cells that make the myelin in the vertebrate central nervous system. An intrinsic timing mechanism operates in each oligodendrocyte precursor cell to limit the length of time the cell divides before terminally differentiating. This mechanism consists of two components, a timing component, which depends on the mitogen platelet-derived growth factor (PDGF) and measures elapsed time, and an effector component, which depends on thyroid hormone and stops cell division and initiates differentiation at the appropriate time. The cell-cycle inhibitor p27/Kip1 accumulates in the precursor cells as they proliferate and is part of both components of the timer. It seems likely that similar timing mechanisms operate in other cell lineages. BioEssays 22:64-71, 2000. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10649292     DOI: 10.1002/(SICI)1521-1878(200001)22:1<64::AID-BIES11>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  79 in total

1.  Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.

Authors:  Eric M Blalock; James W Geddes; Kuey Chu Chen; Nada M Porter; William R Markesbery; Philip W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 2.  Oligodendrocyte Development and Plasticity.

Authors:  Dwight E Bergles; William D Richardson
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-20       Impact factor: 10.005

Review 3.  Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.

Authors:  Siming Shen; Patrizia Casaccia-Bonnefil
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

4.  Induction of human umbilical Wharton's jelly-derived stem cells toward oligodendrocyte phenotype.

Authors:  Elmira Mikaeili Agah; Kazem Parivar; Mohammad Nabiuni; Mehrdad Hashemi; Masoud Soleimani
Journal:  J Mol Neurosci       Date:  2013-09-11       Impact factor: 3.444

5.  Ect2, an ortholog of Drosophila's pebble, negatively regulates neurite outgrowth in neuroblastoma × glioma hybrid NG108-15 cells.

Authors:  Takahiro Tsuji; Chiharu Higashida; Yasumasa Yoshida; Mohammad Saharul Islam; Mitsuko Dohmoto; Keita Koizumi; Haruhiro Higashida
Journal:  Cell Mol Neurobiol       Date:  2011-02-25       Impact factor: 5.046

Review 6.  Mechanisms limiting body growth in mammals.

Authors:  Julian C Lui; Jeffrey Baron
Journal:  Endocr Rev       Date:  2011-03-25       Impact factor: 19.871

7.  Acute oligodendrocyte loss with persistent white matter injury in a third trimester equivalent mouse model of fetal alcohol spectrum disorder.

Authors:  Jessie Newville; Carlos Fernando Valenzuela; Lu Li; Lauren L Jantzie; Lee Anna Cunningham
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

8.  Tauroursodeoxycholic acid increases neural stem cell pool and neuronal conversion by regulating mitochondria-cell cycle retrograde signaling.

Authors:  Joana M Xavier; Ana L Morgado; Cecília Mp Rodrigues; Susana Solá
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives.

Authors:  Hao Huang; Xiao-Feng Zhao; Kang Zheng; Mengsheng Qiu
Journal:  Neurosci Bull       Date:  2013-02-28       Impact factor: 5.203

Review 10.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.